Metallothionein is a Potential Therapeutic Strategy for Amyotrophic Lateral Sclerosis

金属硫蛋白 SOD1 细胞内 肌萎缩侧索硬化 平衡 自噬 氧化应激 药理学 生物 细胞生物学 医学 疾病 生物化学 病理 细胞凋亡 基因
作者
Shin‐ichi Ono
出处
期刊:Current Pharmaceutical Design [Bentham Science Publishers]
卷期号:23 (33) 被引量:5
标识
DOI:10.2174/1381612823666170622105513
摘要

Lou Gehrig's disease, a synonym of amyotrophic lateral sclerosis, is an adult-onset lethal neurodegenerative disorder. Irrespective of extensive efforts to elucidate the pathogenesis of the disease and searches for therapies, no favorable pharmacotherapeutic strategies have yet to be proposed. In a popular rodent model of ALS, G93A SOD1 strain of mouse, intracellular copper conditions were geared toward copper accumulation inside cells, resulting in an acceleration of oxidative stress and apoptotic process. Disruption of intracellular copper homeostasis was common to transgenic mice expressing human mutant SOD1s. In this review, the novel hypothesis that disruption of intracellular copper homeostasis could be involved in the development of the disease was introduced. Based upon the hypothesis, therapeutic outcomes of agents that are capable of correcting and/or modifying intracellular copper homeostasis are described. Administration of ammonium tetrathiomolybdate, a selective intracellular copper chelator, delayed onset, slowed progression, and prolonged survival of a rodent model of the disease (G93A SOD1 mice). Metallothionein is a low molecular weight, cysteine-rich, metal-binding cytoplasmic protein that has beneficial properties in detoxification of toxic heavy metals, homeostatic regulation of intracellular essential trace elements, including copper, antioxidant, and antiapoptotic roles. In animal experiments of the G93A SOD1 mice, an increase of metallothionein proteins by means of induction by exercise or dexamethasone, genetic overexpression, or intraperitoneal administration, all resulted in a preferable outcome. The therapeutic effects were not inferior to those of approved drugs for ALS in humans. These observations suggest that metallothionein could be worth investigating the therapeutic potential in clinical use. Keywords: Metallothionein, intracellular Cu homeostasis, SOD1 mutation, cysteine111, Cu chaperons, Cu secretion.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
Eclipse12138完成签到,获得积分10
1秒前
Lucas应助小柴采纳,获得10
1秒前
1秒前
kidult完成签到,获得积分10
2秒前
3秒前
无私的寄灵完成签到 ,获得积分10
3秒前
minnn应助wu采纳,获得10
3秒前
4秒前
暮色陈陈完成签到,获得积分10
4秒前
kidult发布了新的文献求助10
4秒前
掩饰完成签到,获得积分10
5秒前
满意沛槐完成签到 ,获得积分10
6秒前
sqq689发布了新的文献求助10
6秒前
7秒前
掩饰发布了新的文献求助10
8秒前
暮色陈陈发布了新的文献求助10
8秒前
乐乐应助球球采纳,获得10
8秒前
科研通AI6.3应助渺121采纳,获得10
9秒前
9秒前
10秒前
10秒前
打打应助沉静傥采纳,获得10
11秒前
Akim应助呀呀呀我来啦采纳,获得10
11秒前
12秒前
13秒前
14秒前
14秒前
14秒前
科研通AI6.2应助贪玩黑米采纳,获得10
14秒前
sonicX发布了新的文献求助10
15秒前
852应助一粟的粉r采纳,获得10
16秒前
Miley发布了新的文献求助10
16秒前
16秒前
人福药业完成签到,获得积分10
17秒前
李健应助hrpppp采纳,获得50
17秒前
18秒前
18秒前
牛马鹅发布了新的文献求助10
19秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
模型平均及其应用 900
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 550
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7335830
求助须知:如何正确求助?哪些是违规求助? 8949699
关于积分的说明 18991397
捐赠科研通 6989481
什么是DOI,文献DOI怎么找? 3217759
关于科研通互助平台的介绍 2383830
邀请新用户注册赠送积分活动 2197849